Free Trial

Autolus Therapeutics (AUTL) SEC Filings & 10K Form

Autolus Therapeutics logo
$1.95 0.00 (0.00%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.98 +0.03 (+1.49%)
As of 02/21/2025 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Autolus Therapeutics SEC Filings

DateFilerForm TypeView
01/13/2025
5:47 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:32 PM
Autolus Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SC 13G/A
11/14/2024
8:12 AM
Autolus Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/12/2024
5:56 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
9:52 AM
Autolus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
09/26/2024
6:00 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
7:09 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:02 PM
Autolus Therapeutics (Subject)
Pule Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
8:08 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:27 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:35 PM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
4:15 PM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
3:30 PM
Autolus Therapeutics (Subject)
Blackstone Inc. (Filed by)
Form SC 13D/A
05/17/2024
7:27 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
8:33 AM
Autolus Therapeutics (Filer)
Form NT 10-Q
05/13/2024
6:23 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
6:06 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:10 PM
Autolus Therapeutics (Subject)
Kellnerova Renata (Filed by)
Form SC 13D/A
03/21/2024
3:21 PM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:21 PM
Autolus Therapeutics (Filer)
Form 8-K/A
03/14/2024
11:32 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
4:28 PM
Autolus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AUTL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners